Study of Aripiprazole in Patients With Bipolar I Disorder
Public ClinicalTrials.gov record NCT00257972. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy of Aripiprazole in Combination With Valproate or Lithium in the Treatment of Mania in Patients With Bipolar I Disorder Partially Nonresponsive to Valproate or Lithium Monotherapy
Study identification
- NCT ID
- NCT00257972
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- aripiprazole Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2004
- Primary completion
- Nov 30, 2007
- Completion
- Nov 30, 2007
- Last update posted
- Nov 7, 2013
2004 – 2007
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Little Rock | Arkansas | — | — |
| Local Institution | Riverside | California | — | — |
| Local Institution | Deerfield Beach | Florida | — | — |
| Local Institution | Jacksonville | Florida | — | — |
| Local Institution | Maitland | Florida | — | — |
| Local Institution | Hoffman Estates | Illinois | — | — |
| Local Institution | Oak Brook | Illinois | — | — |
| Local Institution | Newton | Kansas | — | — |
| Local Institution | Newton | Massachusetts | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | Staten Island | New York | — | — |
| Local Institution | Raleigh | North Carolina | — | — |
| Local Institution | Dayton | Ohio | — | — |
| Local Institution | Media | Pennsylvania | — | — |
| Local Institution | Norristown | Pennsylvania | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Columbia | South Carolina | — | — |
| Local Institution | Memphis | Tennessee | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | Bellevue | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00257972, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2013 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00257972 live on ClinicalTrials.gov.